Potvin’s TSDs in the EU [Two-Stage / GS Designs]

posted by Shuanghe  – Spain, 2013-10-31 11:48 (4253 d 12:54 ago) – Posting: # 11836
Views: 7,058

Hi,

❝ .. is principally acceptable. ...


When I saw this I knew something bad gonna happen. :-D

❝ ... However, as the study was stopped for inequivalence, any further considerations on type I error control become obsolete.


OK, that's not what I was expecting.

I don't know if Elmaestro and I were reading the same thing but the hidden line I've got is that:

ok, you are "lucky" that your formulation screwed so you have to stop after stage 1; if you go to stage 2 and the result "appears" OK I'm gonna ask about the alpha inflation, higher patient risk, etc etc...

How's that "... occasionally even Austrians say something meaningful. " :-D

All the best,
Shuanghe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
280 visitors (0 registered, 280 guests [including 1 identified bots]).
Forum time: 01:43 CEST (Europe/Vienna)

Reach for the stars,
even if you have to stand on a cactus.    Susan Longacre

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5